Urology
Volume 75, Issue 6 , Pages 1514.e1-1514.e6, June 2010

Feasibility of 3.0T Magnetic Resonance Imaging-guided Laser Ablation of a Cadaveric Prostate

  • David A. Woodrum

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • Corresponding Author InformationReprint requests: David A. Woodrum, Ph.D., Department of Radiology, Mayo Clinic, 200 First Street, Southwest, Rochester, MN 55905
  • ,
  • Krzysztof R. Gorny

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Lance A. Mynderse

      Affiliations

    • Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Kimberly K. Amrami

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Joel P. Felmlee

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Haraldur Bjarnason

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Oscar I. Garcia-Medina

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Roger J. McNichols

      Affiliations

    • BioTex, Incorporated, Houston, Texas
  • ,
  • Thomas D. Atwell

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
  • ,
  • Matthew R. Callstrom

      Affiliations

    • Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota

Received 23 September 2009; accepted 19 January 2010. published online 09 April 2010.

Objectives

To demonstrate the feasibility of 3.0T magnetic resonance imaging (MRI)-guided laser ablation of the prostate.

Methods

MRI-guided laser ablations in the intact prostate gland were performed in 5 cadavers. The cadavers were brought into the MRI suite and placed in a supine headfirst position. A needle guide grid was placed against the perineum, and MRI was performed to co-localize the grid with the prostate imaging data set. Using the guidance grid and 14-gauge Abbocath catheters, the laser applicators were placed in the prostate with intermittent MRI guidance. After confirmation of the position of the laser applicators, 2-minute ablations were performed with continuous MRI temperature feedback. Using the relative change in temperature and the Arrhenius model of thermal tissue ablation, the ablation margins were calculated.

Results

Laser ablation was successfully performed in all 5 cadaveric prostates using 15- and 30-W laser generators. Thermal mapping in the axial, sagittal, and coronal planes was performed with calculated ablation margins projected back onto the magnitude MR images. Deviations of the needles from the template projections ranged from 1.0 to 4.1 mm (average 2.1) at insertion depths of 75.5-116.5 mm (average 98.2). In the 2 cadavers for which histologic correlation was available, the extent of the ablation zone corresponded to the temperature mapping findings and the ablation transition zones were identifiable on hematoxylin-eosin staining.

Conclusions

Transperineal laser ablation of the prostate gland is possible using 3.0T MRI guidance and thermal mapping and offers the potential for precise image-guided focal targeting of prostate cancer.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by a small grant from Mayo Clinic.

 R. McNichols is an employee of, and equity owner in, Visualase, Incorporated.

PII: S0090-4295(10)00172-X

doi:10.1016/j.urology.2010.01.059

Urology
Volume 75, Issue 6 , Pages 1514.e1-1514.e6, June 2010